InvestmentApr 23, 2026, 06:12 AM
Nektar Therapeutics Raises $350.9M in Common Stock Offering
AI Summary
Nektar Therapeutics entered into an underwriting agreement for an offering of 3,532,609 shares of common stock at $92.00 per share. The underwriters fully exercised their option to purchase an additional 529,891 shares. The company expects to receive approximately $350.9 million in net proceeds from the offering, which is anticipated to close on April 23, 2026.
Key Highlights
- Nektar Therapeutics offered 3,532,609 shares of common stock.
- Underwriters exercised option for 529,891 additional shares.
- Public offering price set at $92.00 per share.
- Expected net proceeds of approximately $350.9 million.
- Offering expected to close on April 23, 2026.